{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T20:19:12Z","timestamp":1782850752076,"version":"3.54.5"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T00:00:00Z","timestamp":1716163200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T00:00:00Z","timestamp":1716163200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Diabetic kidney disease (DKD) stands as the predominant cause of chronic kidney disease and end-stage kidney disease. Its diverse range of manifestations complicates the treatment approach for patients. Although kidney biopsy is considered the gold standard for diagnosis, it lacks precision in predicting the progression of kidney dysfunction. Herein, we addressed whether the presence of glomerular crescents is linked to the outcomes in patients with biopsy-confirmed type 2 DKD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We performed a retrospective evaluation, involving 327 patients diagnosed with biopsy-confirmed DKD in the context of type 2 diabetes, excluding cases with other glomerular diseases, from nine tertiary hospitals. Hazard ratios (HRs) were calculated using a Cox regression model to assess the risk of kidney disease progression, defined as either\u2009\u2265\u200950% decrease in estimated glomerular filtration rates or the development of end-stage kidney disease, based on the presence of glomerular crescents.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Out of the 327 patients selected, ten patients had glomerular crescents observed in their biopsied tissues. Over the follow-up period (median of 19\u00a0months, with a maximum of 18\u00a0years), the crescent group exhibited a higher risk of kidney disease progression than the no crescent group, with an adjusted HR of 2.82 (1.32\u20136.06) (<jats:italic>P<\/jats:italic>\u2009=\u20090.008). The presence of heavy proteinuria was associated with an increased risk of developing glomerular crescents.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The presence of glomerular crescents is indeed linked to the progression of type 2 DKD. Therefore, it is important to determine whether there is an additional immune-mediated glomerulonephritis requiring immunomodulation, and it may be prudent to monitor the histology and repeat a biopsy.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12882-024-03578-y","type":"journal-article","created":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T16:02:02Z","timestamp":1716220922000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Glomerular crescents are associated with the risk of type 2 diabetic kidney disease progression: a retrospective cohort study"],"prefix":"10.1186","volume":"25","author":[{"given":"Sohyun","family":"Bae","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghwan","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Woo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Hyun","family":"Jhee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Pyo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Ik","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieun","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Joo","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Gyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajeong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Ki","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwon Wook","family":"Joo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Chul","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho Jun","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Seok","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,20]]},"reference":[{"key":"3578_CR1","doi-asserted-by":"publisher","first-page":"1497449","DOI":"10.1155\/2021\/1497449","volume":"2021","author":"N Samsu","year":"2021","unstructured":"Samsu N. Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment. Biomed Res Int. 2021;2021:1497449.","journal-title":"Biomed Res Int"},{"key":"3578_CR2","volume-title":"IDF Diabetes Atlas","author":"DJ Magliano","year":"2021","unstructured":"Magliano DJ, Boyko EJ. IDF Diabetes Atlas. 10th ed. Brussels: IDF Diabetes Atlas; 2021.","edition":"10th"},{"issue":"5","key":"3578_CR3","doi-asserted-by":"publisher","first-page":"e307","DOI":"10.1016\/S2214-109X(16)00071-1","volume":"4","author":"B Ene-Iordache","year":"2016","unstructured":"Ene-Iordache B, Perico N, Bikbov B, Carminati S, Remuzzi A, Perna A, et al. Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study. Lancet Glob Health. 2016;4(5):e307\u201319.","journal-title":"Lancet Glob Health"},{"issue":"6","key":"3578_CR4","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/dmrr.2633","volume":"31","author":"K Mise","year":"2015","unstructured":"Mise K, Hoshino J, Ueno T, Hazue R, Sumida K, Hiramatsu R, et al. Clinical and pathological predictors of estimated GFR decline in patients with type 2 diabetes and overt proteinuric diabetic nephropathy. Diabetes Metab Res Rev. 2015;31(6):572\u201381.","journal-title":"Diabetes Metab Res Rev"},{"issue":"2","key":"3578_CR5","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1159\/000514259","volume":"52","author":"JM Chemouny","year":"2021","unstructured":"Chemouny JM, Bobot M, Sannier A, Maisons V, Jourde-Chiche N, Ferriere E, et al. Kidney Biopsy in Type 2 Diabetes: A Multicenter Cross-Sectional Study. Am J Nephrol. 2021;52(2):131\u201340.","journal-title":"Am J Nephrol"},{"issue":"2","key":"3578_CR6","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.nefroe.2020.03.013","volume":"40","author":"F Garcia-Martin","year":"2020","unstructured":"Garcia-Martin F, Gonzalez Monte E, Hernandez Martinez E, BadaBoch T, Bustamante Jimenez NE, Praga TM. When to perform renal biopsy in patients with type2 diabetes mellitus? Predictive model of non-diabetic renal disease. Nefrologia (Engl Ed). 2020;40(2):180\u20139.","journal-title":"Nefrologia (Engl Ed)"},{"issue":"3","key":"3578_CR7","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1159\/000102598","volume":"27","author":"TT Pham","year":"2007","unstructured":"Pham TT, Sim JJ, Kujubu DA, Liu IL, Kumar VA. Prevalence of nondiabetic renal disease in diabetic patients. Am J Nephrol. 2007;27(3):322\u20138.","journal-title":"Am J Nephrol"},{"issue":"4","key":"3578_CR8","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1681\/ASN.2010010010","volume":"21","author":"TW Tervaert","year":"2010","unstructured":"Tervaert TW, Mooyaart AL, Amann K, Cohen AH, Cook HT, Drachenberg CB, et al. Pathologic classification of diabetic nephropathy. J Am Soc Nephrol. 2010;21(4):556\u201363.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"3578_CR9","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.diabres.2012.03.016","volume":"97","author":"SW Oh","year":"2012","unstructured":"Oh SW, Kim S, Na KY, Chae DW, Kim S, Jin DC, et al. Clinical implications of pathologic diagnosis and classification for diabetic nephropathy. Diabetes Res Clin Pract. 2012;97(3):418\u201324.","journal-title":"Diabetes Res Clin Pract"},{"issue":"3","key":"3578_CR10","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.jdiacomp.2015.12.002","volume":"30","author":"X Zhu","year":"2016","unstructured":"Zhu X, Xiong X, Yuan S, Xiao L, Fu X, Yang Y, et al. Validation of the interstitial fibrosis and tubular atrophy on the new pathological classification in patients with diabetic nephropathy: A single-center study in China. J Diabetes Complications. 2016;30(3):537\u201341.","journal-title":"J Diabetes Complications"},{"issue":"1","key":"3578_CR11","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/j.1440-1797.2011.01525.x","volume":"17","author":"T Okada","year":"2012","unstructured":"Okada T, Nagao T, Matsumoto H, Nagaoka Y, Wada T, Nakao T. Histological predictors for renal prognosis in diabetic nephropathy in diabetes mellitus type 2 patients with overt proteinuria. Nephrology (Carlton). 2012;17(1):68\u201375.","journal-title":"Nephrology (Carlton)"},{"issue":"6","key":"3578_CR12","first-page":"367","volume":"45","author":"T Shoji","year":"1996","unstructured":"Shoji T, Kanda T, Nakamura H, Hayashi T, Okada N, Nakanishi I, et al. Are glomerular lesions alternatives to microalbuminuria in predicting later progression of diabetic nephropathy? Clin Nephrol. 1996;45(6):367\u201371.","journal-title":"Clin Nephrol"},{"issue":"2","key":"3578_CR13","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s00441-021-03485-w","volume":"385","author":"PF Zipfel","year":"2021","unstructured":"Zipfel PF, Wiech T, Grone HJ, Skerka C. Complement catalyzing glomerular diseases. Cell Tissue Res. 2021;385(2):355\u201370.","journal-title":"Cell Tissue Res"},{"issue":"Pt A","key":"3578_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.108278","volume":"101","author":"J Tao","year":"2021","unstructured":"Tao J, Zhao J, Qi XM, Wu YG. Complement-mediated M2\/M1 macrophage polarization may be involved in crescent formation in lupus nephritis. Int Immunopharmacol. 2021;101(Pt A): 108278.","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"3578_CR15","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.kint.2017.02.003","volume":"91","author":"H Trimarchi","year":"2017","unstructured":"Trimarchi H, Barratt J, Cattran DC, Cook HT, Coppo R, Haas M, et al. Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group. Kidney Int. 2017;91(5):1014\u201321.","journal-title":"Kidney Int"},{"issue":"4","key":"3578_CR16","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.kint.2017.11.023","volume":"93","author":"IM Bajema","year":"2018","unstructured":"Bajema IM, Wilhelmus S, Alpers CE, Bruijn JA, Colvin RB, Cook HT, et al. Revision of the International Society of Nephrology\/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices. Kidney Int. 2018;93(4):789\u201396.","journal-title":"Kidney Int"},{"issue":"3","key":"3578_CR17","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/imj.15702","volume":"52","author":"JE Schroers","year":"2022","unstructured":"Schroers JE, Gilbert AM, McKenzie PR, Kirwan PD, Chadban SJ, Ying T. Rapidly progressive crescentic diabetic nephropathy: two case reports. Intern Med J. 2022;52(3):479\u201384.","journal-title":"Intern Med J"},{"key":"3578_CR18","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1746-1596-7-46","volume":"7","author":"N Otani","year":"2012","unstructured":"Otani N, Akimoto T, Yumura W, Matsubara D, Iwazu Y, Numata A, et al. Is there a link between diabetic glomerular injury and crescent formation? A case report and literature review. Diagn Pathol. 2012;7:46.","journal-title":"Diagn Pathol"},{"issue":"6","key":"3578_CR19","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/nep.12409","volume":"20","author":"N Wakabayashi","year":"2015","unstructured":"Wakabayashi N, Takeda S, Imai T, Akimoto T, Nagata D. Unexpected observation of glomerular crescents in a patient with diabetes who developed drug-induced acute tubulointerstitial nephritis: A possible feature of diabetic nephropathy? Nephrology (Carlton). 2015;20(6):438\u20139.","journal-title":"Nephrology (Carlton)"},{"issue":"1","key":"3578_CR20","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s12882-023-03204-3","volume":"24","author":"M Morimoto","year":"2023","unstructured":"Morimoto M, Namba-Hamano T, Notsu S, Iwata Y, Yasuhara Y, Yamato M, et al. Diabetic nephropathy with marked extra-capillary cell proliferation: a case report. BMC Nephrol. 2023;24(1):139.","journal-title":"BMC Nephrol"},{"issue":"3","key":"3578_CR21","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/BF02549874","volume":"19","author":"T Toth","year":"1987","unstructured":"Toth T. Epithelial crescent in diabetic glomeruli. A case report Int Urol Nephrol. 1987;19(3):347\u201353.","journal-title":"A case report Int Urol Nephrol"},{"issue":"10","key":"3578_CR22","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.1210\/clinem\/dgac416","volume":"107","author":"L Sun","year":"2022","unstructured":"Sun L, Duan T, Zhao Q, Xu L, Han Y, Xi Y, et al. Crescents, an Independent Risk Factor for the Progression of Type 2 Diabetic Kidney Disease. J Clin Endocrinol Metab. 2022;107(10):2758\u201368.","journal-title":"J Clin Endocrinol Metab"},{"key":"3578_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2019.107809","volume":"155","author":"S Jiang","year":"2019","unstructured":"Jiang S, Yu T, Zhang Z, Fang J, Wang Y, Yang Y, et al. Prognostic nomogram and score to predict renal survival of patients with biopsy-proven diabetic nephropathy. Diabetes Res Clin Pract. 2019;155: 107809.","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"3578_CR24","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s10157-020-01859-y","volume":"24","author":"A Saito","year":"2020","unstructured":"Saito A, Komatsuda A, Saito M, Kaga H, Abe F, Sawamura M, et al. Clinicopathological features and outcomes of diabetic kidney disease with extracapillary hypercellularity: a Japanese single-center experience. Clin Exp Nephrol. 2020;24(6):509\u201317.","journal-title":"Clin Exp Nephrol"},{"issue":"1","key":"3578_CR25","doi-asserted-by":"publisher","first-page":"4658","DOI":"10.1038\/s41598-021-83856-z","volume":"11","author":"L Zhao","year":"2021","unstructured":"Zhao L, Liu F, Li L, Zhang J, Wang T, Zhang R, et al. Solidified glomerulosclerosis, identified using single glomerular proteomics, predicts end-stage renal disease in Chinese patients with type 2 diabetes. Sci Rep. 2021;11(1):4658.","journal-title":"Sci Rep"},{"issue":"9","key":"3578_CR26","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604\u201312.","journal-title":"Ann Intern Med"},{"key":"3578_CR27","volume-title":"Crescentic Glomerulonephritis","author":"MS Parmar","year":"2024","unstructured":"Parmar MS, Bashir K. Crescentic Glomerulonephritis. Treasure Island (FL): StatPearls; 2024."},{"key":"3578_CR28","volume-title":"Rapidly Progressive Glomerulonephritis","author":"RH Naik","year":"2023","unstructured":"Naik RH, Shawar SH. Rapidly Progressive Glomerulonephritis. Treasure Island (FL): StatPearls; 2023."},{"issue":"4","key":"3578_CR29","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/labinvest.2015.164","volume":"96","author":"B Suarez-Alvarez","year":"2016","unstructured":"Suarez-Alvarez B, Liapis H, Anders HJ. Links between coagulation, inflammation, regeneration, and fibrosis in kidney pathology. Lab Invest. 2016;96(4):378\u201390.","journal-title":"Lab Invest"},{"issue":"5","key":"3578_CR30","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1053\/j.ajkd.2016.09.002","volume":"68","author":"AB Fogo","year":"2016","unstructured":"Fogo AB, Lusco MA, Najafian B, Alpers CE. AJKD Atlas of Renal Pathology: Pauci-immune Necrotizing Crescentic Glomerulonephritis. Am J Kidney Dis. 2016;68(5):e31\u20132.","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"3578_CR31","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1093\/ndt\/gfz043","volume":"35","author":"A Chen","year":"2020","unstructured":"Chen A, Lee K, Guan T, He JC, Schlondorff D. Role of CD8+ T cells in crescentic glomerulonephritis. Nephrol Dial Transplant. 2020;35(4):564\u201372.","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"3578_CR32","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1097\/MNH.0000000000000596","volume":"29","author":"L Anguiano","year":"2020","unstructured":"Anguiano L, Kain R, Anders HJ. The glomerular crescent: triggers, evolution, resolution, and implications for therapy. Curr Opin Nephrol Hypertens. 2020;29(3):302\u20139.","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"5","key":"3578_CR33","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nrneph.2017.31","volume":"13","author":"A Flyvbjerg","year":"2017","unstructured":"Flyvbjerg A. The role of the complement system in diabetic nephropathy. Nat Rev Nephrol. 2017;13(5):311\u20138.","journal-title":"Nat Rev Nephrol"},{"key":"3578_CR34","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.3389\/fimmu.2020.02073","volume":"11","author":"S Duan","year":"2020","unstructured":"Duan S, Sun L, Nie G, Chen J, Zhang C, Zhu H, et al. Association of Glomerular Complement C4c Deposition With the Progression of Diabetic Kidney Disease in Patients With Type 2 Diabetes. Front Immunol. 2020;11:2073.","journal-title":"Front Immunol"},{"issue":"4","key":"3578_CR35","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.diabet.2018.08.011","volume":"45","author":"ZJ Sun","year":"2019","unstructured":"Sun ZJ, Li XQ, Chang DY, Wang SX, Liu G, Chen M, et al. Complement deposition on renal histopathology of patients with diabetic nephropathy. Diabetes Metab. 2019;45(4):363\u20138.","journal-title":"Diabetes Metab"},{"issue":"6","key":"3578_CR36","first-page":"687","volume":"33","author":"IB Elfenbein","year":"1975","unstructured":"Elfenbein IB, Reyes JW. Crescents in diabetic glomerulopathy. Incidence and clinical significance Lab Invest. 1975;33(6):687\u201395.","journal-title":"Incidence and clinical significance Lab Invest"},{"issue":"10","key":"3578_CR37","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1681\/ASN.V12102060","volume":"12","author":"ML Hir","year":"2001","unstructured":"Hir ML, Keller C, Eschmann V, Hahnel B, Hosser H, Kriz W. Podocyte bridges between the tuft and Bowman\u2019s capsule: an early event in experimental crescentic glomerulonephritis. J Am Soc Nephrol. 2001;12(10):2060\u201371.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"3578_CR38","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.humpath.2013.10.030","volume":"45","author":"JP Gaut","year":"2014","unstructured":"Gaut JP, Hoshi M, Jain S, Liapis H. Claudin 1 and nephrin label cellular crescents in diabetic glomerulosclerosis. Hum Pathol. 2014;45(3):628\u201335.","journal-title":"Hum Pathol"},{"issue":"6","key":"3578_CR39","doi-asserted-by":"publisher","first-page":"F1157","DOI":"10.1152\/ajprenal.2001.281.6.F1157","volume":"281","author":"AF Drew","year":"2001","unstructured":"Drew AF, Tucker HL, Liu H, Witte DP, Degen JL, Tipping PG. Crescentic glomerulonephritis is diminished in fibrinogen-deficient mice. Am J Physiol Renal Physiol. 2001;281(6):F1157\u201363.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"1","key":"3578_CR40","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/0046-8177(93)90066-P","volume":"24","author":"LC Stout","year":"1993","unstructured":"Stout LC, Kumar S, Whorton EB. Focal mesangiolysis and the pathogenesis of the Kimmelstiel-Wilson nodule. Hum Pathol. 1993;24(1):77\u201389.","journal-title":"Hum Pathol"},{"issue":"11","key":"3578_CR41","doi-asserted-by":"publisher","first-page":"5425","DOI":"10.3390\/ijms22115425","volume":"22","author":"D Santoro","year":"2021","unstructured":"Santoro D, Torreggiani M, Pellicano V, Cernaro V, Messina RM, Longhitano E, et al. Kidney Biopsy in Type 2 Diabetic Patients: Critical Reflections on Present Indications and Diagnostic Alternatives. Int J Mol Sci. 2021;22(11):5425.","journal-title":"Int J Mol Sci."},{"issue":"3","key":"3578_CR42","doi-asserted-by":"publisher","first-page":"401","DOI":"10.2215\/CJN.07650711","volume":"7","author":"G Zoppini","year":"2012","unstructured":"Zoppini G, Targher G, Chonchol M, Ortalda V, Negri C, Stoico V, et al. Predictors of estimated GFR decline in patients with type 2 diabetes and preserved kidney function. Clin J Am Soc Nephrol. 2012;7(3):401\u20138.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"10","key":"3578_CR43","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1093\/ndt\/gfad052","volume":"38","author":"W Kriz","year":"2023","unstructured":"Kriz W, Lowen J, Grone HJ. The complex pathology of diabetic nephropathy in humans. Nephrol Dial Transplant. 2023;38(10):2109\u201319.","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"3578_CR44","doi-asserted-by":"publisher","first-page":"F600","DOI":"10.1152\/ajprenal.00669.2020","volume":"321","author":"J Lowen","year":"2021","unstructured":"Lowen J, Grone EF, Gross-Weissmann ML, Bestvater F, Grone HJ, Kriz W. Pathomorphological sequence of nephron loss in diabetic nephropathy. Am J Physiol Renal Physiol. 2021;321(5):F600\u201316.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"2","key":"3578_CR45","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/ndt\/gfu250","volume":"30","author":"Y An","year":"2015","unstructured":"An Y, Xu F, Le W, Ge Y, Zhou M, Chen H, et al. Renal histologic changes and the outcome in patients with diabetic nephropathy. Nephrol Dial Transplant. 2015;30(2):257\u201366.","journal-title":"Nephrol Dial Transplant"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-024-03578-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-024-03578-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-024-03578-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T17:02:48Z","timestamp":1716224568000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-024-03578-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,20]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3578"],"URL":"https:\/\/doi.org\/10.1186\/s12882-024-03578-y","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,20]]},"assertion":[{"value":"9 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the institutional review board of the Seoul National University Hospital (no. H-2209\u2013012-1355) and was conducted in accordance with the ethical standard outlined in the Declaration of Helsinki. Informed consent was waived of the study by the institutional review board of the Seoul National University Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"172"}}